- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 17 - Evolving Guidelines for the Treatment of Cardiometabolic Events
As guidelines to treat the risk factors of cardiovascular disease continue to evolve, Michael Weber, MD, explains how new editions of lipid, diabetes, and hypertension guidelines continue to improve patient care.
Dr Weber explains that we should not expect to see major changes as new treatment guidelines continue to develop, however, since last published several years ago, these guidelines are helpful because they are based on evidence, which is the basis to a good set of guidelines.
Dr Weber is confident in the decisions highlighted inside new guidelines by organized bodies such as the American Diabetes Association, National Kidney Foundation, and Joint National Committee because he feels that these bodies are putting a lot of effort into creating them.
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
